NCT04649216View on ClinicalTrials.gov

Excretion Balance, PK and Metabolism of a Single Oral Dose of [14C]PCO371

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

PCO371

PCO371 Capsule

DRUG

[14C]PCO371

\[14C\]PCO371 Oral solution

DRUG

[14C]PCO371

\[14C\]PCO371 Solution for infusion

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY